Resistin and visfatin concentrations are related to central obesity and inflammation in Brazilian children
Tóm tắt
The evidence that cardiovascular disease begins in childhood and adolescence, especially in the presence of excess weight, is associated with dysfunction on adipokine pro-inflammatory secretion. These affect glucose metabolism and lead to other complications related to insulin resistance and cardiovascular disease. This study assessed the association of anthropometric and metabolic parameters related to obesity, cardiovascular risk, and insulin resistance with concentrations of resistin and visfatin, in children. A cross-sectional study was developed with 178 children of 6–10 years old enrolled in public city schools. Anthropometric data, composition body, clinical, and biochemical were measured according to standard procedures. We used multiple regression models by stepwise method to evaluate the associations of resistin and visfatin with variables of interest. In healthy weight children, resistin was associated with LDL cholesterol, visfatin, atherogenic index, and waist-to-height ratio, whereas in obese children resistin was associated with visfatin and interaction between conicity index and HOMA-AD. Furthermore, in healthy weight children, visfatin was associated to resistin and triceps skinfold thickness and negatively associated to HOMA-AD, while in obese ones visfatin was associated with waist-to-height ratio, atherogenic index, resistin, and interaction between trunk adiposity index and adiponectin and was negatively associated with the HOMA-IR index. Our study shows an association between anthropometric and biochemical variables related to visceral fat and inflammation. These results suggest the resistin and visfatin as good pro-inflammatory markers. In addition, both adipokines are strongly related to central obesity, in children.
Tài liệu tham khảo
Stastny J, Bienertova-Vasku J, Vasku A. Visfatin and its role in obesity development. Diabetes & metabolic syndrome. 2012;6:120–4.
AL-Suhaimi EA, Shehzad A. Lepitin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res. 2013;18:12.
Iantorno M, Campia U, Di Daniele N, Nistico S, Forleo GB, Cardillo C, et al. Obesity, inflammation and endothelial dysfunction. J Biol Regul Homeost Agents. 2014;28:169–76.
Olza J, Aguilera CM, Gil-Campos M, Leis R, Bueno G, Vall M, et al. Waist-to-height ratio, inflammation and CVD risk in obese children. Public Health Nutr. 2014;17:2378–85.
Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab. 2006;91:3165–70.
Maffeis C, Banzato C, Talamini G. Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr. 2008;152:207–13.
Kuba VM, Leone C, Damiani D. Is waist-to-height ratio a useful indicator of cardio-metabolic risk in 6-10-year-old children? BMC Pediatr. 2013;13:91.
Alvarez MM, Vieira ACRE, Sichieri R, Veiga GVD. Associação das medidas antropométricas de localização de gordura central com os componentes da síndrome metabólica em uma amostra probabilística de adolescentes de escolas públicas. Arq Bras Endocrinol Metabol. 2008;52:649–57.
Magalhães EIS, Sant’Ana LFR, Priore SE, Franceschini SDCC. Waist circumference, waist/height ratio, and neck circumference as parameters of central obesity assessment in children. Rev Paul Pediatr. 2014;32:273–81.
Marrodán MD, Álvarez JRM, Espinosa MGM, López-Ejeda N, Cabañas MD, Prado C. Precisión diagnóstica del índice cintura-talla para la identificación del sobrepeso y de la obesidad infantil. Med Clin (Barc). 2012;140:296–301.
Nambiar S, Hughes I, Davies PS. Developing waist-to-height ratio cut-offs to define overweight and obesity in children and adolescents. Public Health Nutr. 2010;13:1566–74.
Petroff D, Kromeyer-Hauschild K, Wiegand S, Binder G, Schwab K, Stachow R, et al. Introducing excess body weight in childhood and adolescence and comparison with body mass index and waist-to-height ratio. Int J Obes. 2015;39:52–60.
Curat CA, Wegner V, Sengenès C, Miranville A, Tonus C, Busse R, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia. 2006;49:744–7.
Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010–3.
Rae C, Graham A. Human resistin promotes macrophage lipid accumulation. Diabetologia. 2006;49:1112–4.
Calabro P, Cirillo P, Limongelli G, Maddaloni V, Riegler L, Palmieri R, et al. Tissue factor is induced by resistin in human coronary artery endothelial cells by the NF-kB-dependent pathway. J Vasc Res. 2011;48:59–66.
Maggio ABR, Wacker J, Montecucco F, Galan K, Pelli G, Mach F, et al. Serum resistin and inflammatory and endothelial activation markers in obese adolescents. J Pediatr. 2012;161:1022–7.
Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1–16.
Martos-Moreno GA, Kopchick JJ, Argente J. Adipoquinas en el niño sano y con obesidad. An Pediatr (Barc). 2013;78:189.
Araki S, Dobashi K, Kubo K, Kawagoe R, Yamamoto Y, Kawada Y, et al. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children. Obesity. 2008;16:384–8.
van Diepen J, Berbée J, Havekes L, Rensen PC. Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis. 2013;228:306–15.
Md O, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660–7.
Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Illinois: Human Kinetics Books; 1991.
Cook D, Mendall M, Whincup PH, Carey IM, Ballam L, Morris JE, et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000;149:139–50.
Valdez R. A simple model-based index of abdominal adiposity. J Clin Epidemiol. 1991;44:955–6.
Haffner S, Stern M, Hazuda HP, Pugh J, Patterson JK. Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non-insulin-dependent diabetes mellitus, lipids, and lipoproteins. Diabetes. 1987;36:43–51.
Slaughter M, Lohman T, Boileau R, Horswill CA, Stillman RJ, Van Loan MD, et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol. 1988;60:709–23.
Matthews D, Hosker J, Rudenski A, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
Matsuhisa M, Yamasaki Y, Emoto M, Shimabukuro M, Funahashi T, Matsuzawa Y. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects. Diabetes Res Clin Pract. 2007;77:151–4.
Katz A, Nambi S, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–10.
Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
Castelli W. Cholesterol and lipids in the risk of coronary artery disease—the Framingham heart study. The Canadian journal of cardiology. 1988; 4 Suppl A: 5A-10A.
Charnet R, Freire CAL, Charnet EMR, BONVINO H, CHARNET R. Análise de Modelos de Regressão Linear – com aplicações. 2ed. Campinas: UNICAMP; 2008.
Montgomery DC, Peck EA, Vining GG. Introduction to linear regression analysis 5a ed. New York: John Wiley John Wiley & Sons; 2012.
O’brien RM. A caution regarding rules of thumb for variance inflation factors. Quality & Quantity. 2007;41:673–90.
Jaleel A, Aheed B, Jaleel S, Majeed R, Zuberi A, Khan S, et al. Association of adipokines with obesity in children and adolescents. Biomark Med. 2013;7:731–5.
Ko B-J, Lee M, Park HS, Han K, Cho GJ, Hwang TG, et al. Elevated vaspin and leptin levels are associated with obesity in prepubertal Korean children. Endocr J. 2013;60:609–16.
Rubin DA, McMurray RG, Hackney AC, Harrell JS. Relationship between cardiovascular risk factors and adipokines in adolescents. Hormone research in paediatrics. 2011;76:123–9.
Ortega L, Riestra P, Navarro P, Gavela-Pérez T, Soriano-Guillén L, Garcés C. Resistin levels are related to fat mass, but not to body mass index in children. Peptides. 2013;49:49–52.
Martos-Moreno G, Kratzsch J, Körner A, Barrios V, Hawkins F, Kiess W, et al. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int J Obes. 2011;35:1–8.
Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121:2094–101.
Haider DG, Holzer G, Schaller G, Weghuber D, Widhalm K, Wagner O, et al. The adipokine visfatin is markedly elevated in obese children. J Pediatr Gastroenterol Nutr. 2006;43:548–9.
Davutoglu M, Ozkaya M, Guler E, Garipardic M, Gursoy H, Karabiber H, et al. Plasma visfatin concentrations in childhood obesity relationships with insulin resistance and anthropometric indices. Swiss Med Wkly. 2009;139:22–7.
Kolsgaard ML, Wangensteen T, Brunborg C, Joner G, Holven KB, Halvorsen B, et al. Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome. Scand J Clin Lab Invest. 2009;69:858–64.
Savino F, Petrucci E, Nanni G. Adiponectin: an intriguing hormone for paediatricians. Acta Paediatr. 2008;97:701–5.
Riestra P, Garcia-Anguita A, Lasuncion MA, Cano B, de Oya M, Garcés C. Relationship of adiponectin with metabolic syndrome components in pubertal children. Atherosclerosis. 2011;216:467–70.
Bastien M, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369–81.
Domingos ALG, Coelho GLLM, Volp ACP, Oliveira FLPD, Caldas IS, Freitas SN. Association between nutritional status, C-reactive protein, adiponectin and HOMA-AD in Brazilian children. Nutr Hosp. 2014;30:66–74.
Chen X-Y, Zhang J-H, Liu F, Liu HM, Song YY, Liu YL. Association of serum resistin levels with metabolic syndrome and early atherosclerosis in obese Chinese children. J Pediatr Endocrinol Metab. 2013;26:855–60.
Glass C, Olefsky J. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15:635–45.
Diepen JAv, Berbée JFP, Havekes LM, Rensen PC. Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis 2013;228:306–315.
Taşçılar ME, Çekmez F, Meral C, Pirgon Ö, Tanju IA, Canpolat FE. Evaluation of adipocytokines in obese children with insulin resistance. Turk J Pediatr. 2011;53:269–73.
Kim HJ, Park SY, Choi YJ, Han SJ, Lee KW, Kim DJ. Differential significance of plasma visfatin concentrations according to adiposity in children and adolescents. Horm Res Paediatr. 2013;79:208–13.
Krzystek-Korpacka M, Patryn E, Bednarz-Misa I, Hotowy K, Noczynska A. Visfatin in juvenile obesity—the effect of obesity intervention and sex. Eur J Clin Investig. 2011;41:1284–91.
Sant'Ana MSL, Tinôco ALA, Sant'Ana LFDR, Rosado LEFPD, Santos TF, Mello AD, et al. Eficácia do índice de conicidade e da relação cintura/estatura em predizer o percentual de gordura corporal em crianças. Nutrire. 2010;35:67–80.
Taylor RW, Jones IE, Williams SM, Goulding A. Evaluation of waist circumference, waist-to-hip ratio, and the conicity index as screening tools for high trunk fat mass, as measured by dual-energy X-ray absorptiometry, in children aged 3-19 y. Am J Clin Nutr. 2000;72:490–5.
Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:e500–3.